A NOVEL G/A AND THE 4G/5G POLYMORPHISM WITHIN THE PROMOTER OF THE PLASMINOGEN ACTIVATOR INHIBITOR-1 GENE IN PATIENTS WITH DEEP VEIN THROMBOSIS

This publication has 16 references indexed in Scilit:

• The Significance of Hypofibrinolysis for the Risk of Recurrence of Venous Thromboembolism
  Thrombosis and Haemostasis, 1996
• Allele-specific increase in basal transcription of the plasminogen-activator inhibitor 1 gene is associated with myocardial infarction.
  Proceedings of the National Academy of Sciences, 1995
• Involvement of the hemostatic system in the insulin resistance syndrome. A study of 1500 patients with angina pectoris. The ECAT Angina Pectoris Study Group.
  Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1993
• Genetic variation at the plasminogen activator inhibitor-1 locus is associated with altered levels of plasma plasminogen activator inhibitor-1 activity.
  Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1991
• Plasminogen activator inhibitor activity and other fibrinolytic variables in patients with coronary artery disease.
  Heart, 1988
• PLASMINOGEN ACTIVATOR INHIBITOR IN PLASMA: RISK FACTOR FOR RECURRENT MYOCARDIAL INFARCTION
  The Lancet, 1987
• Increased concentration of the fast‐acting plasminogen activator inhibitor in plasma associated with familial venous thrombosis
  British Journal of Haematology, 1987
• Correlation between blood fibrinolytic activity, plasminogen activator inhibitor level, plasma insulin level, and relative body weight in normal and obese subjects
  Metabolism, 1986
• Plasminogen activator inhibitor in the blood of patients with coronary artery disease.
  BMJ, 1985
• Defective fibrinolysis in survivors of myocardial infarction
  International Journal of Cardiology, 1984